Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study
Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA
Abigail E. Calder, Gregor Hasler
Journal of Affective Disorders (2024) Vol. 365, pp. 258-264
Open Access | Times Cited: 8
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access
Psychedelic group-based integration: ethical assessment and initial recommendations
Katherine Cheung, Caleigh Propes, Edward Jacobs, et al.
International Review of Psychiatry (2024), pp. 1-11
Closed Access | Times Cited: 3
Treatment-resistant depression: molecular mechanisms and management
Mayanja Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic
Anthony L. Back, Timara K. Freeman-Young, David L. Morgan, et al.
JAMA Network Open (2024) Vol. 7, Iss. 12, pp. e2449026-e2449026
Closed Access | Times Cited: 3
Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials
G. Salvetti, Daniele Saccenti, Andrea Stefano Moro, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 829-829
Open Access | Times Cited: 2
Patient and provider perspectives on the phenomenon and effective treatment of treatment-resistant depression: A grounded theory
Aubrey Bornhoff, Edward B. Davis, Jonathon Yousey, et al.
Journal of Affective Disorders Reports (2024) Vol. 16, pp. 100779-100779
Open Access | Times Cited: 1
Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA
Abigail E. Calder, Gregor Hasler
(2024)
Open Access | Times Cited: 1
Exploring inner depths
Joost Breeksema
(2024)
Open Access
Psychedelic experiences in psychedelic-assisted therapy for depression
Uzair Khan
Philosophical Psychology (2024), pp. 1-24
Open Access
Patient experiences of treatment-resistant depression (TRD): A systematic review and qualitative meta-synthesis
Alexandra Cernat, Manisha Pahwa, Dima Hadid, et al.
PLOS mental health. (2024) Vol. 1, Iss. 6, pp. e0000128-e0000128
Open Access
Perspectivas atuais sobre o uso de psilocibina no manejo da depressão resistente: revisão sistemática
Celina Rodrigues Maia Santos, João Gabriel de Almeida Sousa, Eva Maria Oliveira Cutrim Dantas, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 2, pp. e68272-e68272
Open Access
Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol
J Pincombe, M.L. Williams, Sean P. Carruthers, et al.
(2024)
Open Access
Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review
Gerrit Viljoen, Felix Betzler
Current topics in behavioral neurosciences (2024)
Closed Access
Ethical Aspects of Psychedelic-Assisted Treatments: An Overview
Christopher Poppe, Dimitris Repantis
Current topics in behavioral neurosciences (2024)
Closed Access
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders
Vivian Kim, Scott Wilson, Mary E. Woesner
Journal of Clinical Psychopharmacology (2024)
Closed Access
The Polypharmacology of Cariprazine and its Implications to Clinical Indications
Attila Egyed, Dóra Kiss, György M. Keserü
(2024), pp. 385-404
Closed Access
Page 1

Scroll to top